Home News Bones and Joints and Muscles News Higher Disease Burden for OA Than RA After Six Months

Higher Disease Burden for OA Than RA After Six Months

Similar disease burden seen at presentation for osteoarthritis, rheumatoid arthritis

WEDNESDAY, March 27, 2019 (HealthDay News) — After six months, osteoarthritis (OA) is associated with higher mean disease burden than rheumatoid arthritis (RA), according to a study published online March 20 in Arthritis & Rheumatology.

Jacquelin R. Chua, M.D., from the Rush University Medical Center in Chicago, and colleagues examined disease burden in OA according to multidimensional health assessment questionnaire/routine assessment of patient index data (MDHAQ/RAPID3) at initial and six-month follow-up visits compared to RA as a high disease burden benchmark.

The researchers found that the mean RAPID3 did not differ significantly in OA patients versus disease-modifying antirheumatic drug (DMARD)-naive RA patients at the initial visit (range, 14.8 to 16.4; P = 0.38) or in all OA patients versus DMARD-naive RA patients versus prior-DMARD RA patients (16.0, 15.5, and 15.6, respectively; P = 0.49). Substantially more improvement was seen in RAPID3 in RA patients than in OA patients after six months. For most self-report measures and in adjusted analyses, the results were similar.

“This new information may have important implications for public health and control of health care costs,” a coauthor said in a statement. “Our results appear to indicate an urgent need for improved treatments and strategies for prevention of osteoarthritis.”

One author holds a copyright and trademark on MDHAQ and RAPID3 for which they receive royalties and license fees.

Abstract/Full Text (subscription or payment may be required)

Copyright © 2019 HealthDay. All rights reserved.